Dr. Anita Fallah is a postdoctoral researcher at the Nuffield Department of Surgical Sciences, University of Oxford. She holds a Pharm.D. and a Ph.D. in Pharmacology and Toxicology. Her research focuses on developing focused ultrasound (FUS)-based therapies for pancreatic cancer, exploring how US-mediated tumour ablation and targeted drug delivery can enhance the efficacy of existing therapies and improve responses to immunotherapy. Her work integrates biomedical engineering with translational cancer research to advance innovative therapies. Her broader research interests include cancer biology, translational medicine, and advanced drug delivery technologies.